Drawing for PXP

USPTO serial 87581243

PXP

Reviewed by CopyMark Law Group

Reg. 5633933Status 702Registered
Filing date
Status date
Registration date
Dec 18, 2018
Examiner
PATEL, SAMIR RAMESH
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with PXP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Autologous blood transfusion apparatus for scientific use; blood processing equipment for scientific use, namely, apparatus for the autologous processing and recovery of blood; blood taking and transfusion apparatus, namely, blood recovery device used for taking, drawing, collecting, separating, concentrating and re-infusing autologous blood for scientific purposes; Scientific apparatus, instruments and devices for taking blood, collecting blood, pumping blood, separating blood, concentrating separated components of blood, filtering blood, testing blood and blood analysisACTIVESep 30, 2018
010Autologous blood transfusion apparatus for point of care use; blood processing equipment for medical use, namely, apparatus for the autologous processing and recovery of blood; blood taking and transfusion apparatus, namely, blood recovery device used for taking, drawing, collecting, separating, concentrating and re-infusing autologous blood for clinical and medical purposes; Medical, clinical and surgical apparatus, instruments and devices for taking blood, collecting blood, pumping blood, separating blood, concentrating separated components of blood, filtering blood, testing blood and blood analysisACTIVESep 30, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 1, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 1, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 1, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 27, 2025E815TEAS SECTION 8 & 15 RECEIVED
Mar 20, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 20, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 6, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 6, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 15, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 15, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 15, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 15, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 15, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 18, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 7, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 7, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 18, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 16, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 15, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 9, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE
Nov 9, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 12, 2018IUAFUSE AMENDMENT FILED
Oct 12, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 30, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2018EX1GSOU EXTENSION 1 GRANTED
Jun 28, 2018EXT1SOU EXTENSION 1 FILED
Jun 28, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 6, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 12, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 12, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 3, 2017ALIEASSIGNED TO LIE
Oct 20, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2017XAECEXAMINER'S AMENDMENT ENTERED
Oct 20, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 20, 2017GNEAEXAMINERS AMENDMENT E-MAILED
Oct 20, 2017CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 11, 2017DOCKASSIGNED TO EXAMINER
Aug 29, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 26, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance